← SynDRA
VABICASERIN
SynDRA canonical compound SYN0033352 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR2A | HTR2B | HTR2C |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
| Indication | schizophrenia |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- HTR2C AGONIST
- Serotonin 2c (5-HT2c) receptor agonist
- HTR2B ANTAGONIST
- Serotonin 2b (5-HT2b) receptor antagonist
- HTR2A ANTAGONIST
- Serotonin 2a (5-HT2a) receptor antagonist
- serotonin receptor agonist
- HTR2B MODULATOR
- HTR2C MODULATOR
Cross-references
Synonyms
- Vabicaserine
- Vabicaserina
- Vabicaserin hydrochloride
- PF-05208769
- PF-5208769
- SCA-136
- WY-16629
- WD9550HPNL
- vabicaserinum
- RefChem:901531
- DTXCID101766771
- DTXCID501405022
- Vabicaserin [INN]
- UNII-WD9550HPNL
- (-)-Vabicaserin
- Vabicaserin free base
- VABICASERIN [WHO-DD]
- SCHEMBL2980790
- SCHEMBL29360834
- BDBM50076216
- NS00071905
- وابیکاسرین
- バビカセリン
- D06660
- orb1308966
- RefChem:193456
- Vabicaserin hydrochloride (SCA 136)
- GLXC-04945
- UNII-2759C7222C
- T13275
- MFCD31706226
- VABICASERIN HYDROCHLORIDE [WHO-DD]
- MKB25894
- MS-23744
- Vabicaserin hydrochloride [USAN]
- SCHEMBL29539117
- Vabicaserin hydrochloride (USAN)
- FV176511
Look up VABICASERIN in the interactive SynDRA portal →